Rankings
▼
Calendar
ARQT
Arcutis Biotherapeutics, Inc.
$3B
FY 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$4M
Net Income
-$5M
EPS (Diluted)
$-4.71
Cash Flow
Operating Cash Flow
-$4M
Free Cash Flow
-$4M
Stock-Based Comp.
$27,000
Balance Sheet
Total Assets
$4M
Total Liabilities
$9M
Stockholders' Equity
-$5M
Cash & Equivalents
$3M
← Q1 2018
All Quarters
ARQT FY 2017 Earnings — Arcutis Biotherapeutics, Inc. Revenue & Financial Results | Market Cap Arena
